Claims
- 1. A catalytic organometallic composition, effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at an allylic position, said composition comprising: a metal atom selected from the group consisting of molybdenum, tungsten, and chromium, and coordinated thereto, a chiral ligand L1 comprising:
a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group —NH—(C═O)—B, wherein said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; each group B is independently selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp2 hybridized ring nitrogen atom effective to coordinate to said metal atom; and at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring.
- 2. The composition of claim 1, wherein
(i) each said group B is a group CyN as defined in claim 1, or (ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim 1; or (iii) both (i) and (ii) are present.
- 3. The composition of claim 1, wherein at least one group B is a group CyN having an sp2 hybridized ring nitrogen which is α to a ring carbon atom which is linked to the carbonyl (C═O) carbon of said binding group.
- 4. The composition of claim 1, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring.
- 5. The composition of claim 4, wherein said ring is a carbocyclic ring having 5-7 ring atoms, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon, and may be fused to an additional ring.
- 6. The composition of claim 5, wherein said heterocyclic ring has 1 to 2 ring atoms selected from oxygen and nitrogen.
- 7. The composition of claim 1, wherein said group or groups CyN are independently selected from pyridyl, quinolinyl, isoquinolyl, pyrimidyl, triazinyl, tetrazinyl, pyrazinyl, pyrazolyl, triazolyl, tetrazolyl, oxazinyl, oxazolyl, thiazolyl, imidazolyl, benzoxazole, benzimidazole, and dihydro derivatives of the above.
- 8. The composition of claim 3, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, 2-benzoxazole, 2-benzimidazole, and dihydro derivatives of the above.
- 9. The composition of claim 1, wherein said carbon atoms are connected by a direct bond.
- 10. The composition of claim 9, wherein said chiral component is selected from 1R,2R-trans-diaminocyclohexane, 1R,2R-trans-diphenyl-1 ,2-ethanediamine, 3R, 4R-trans-3,4-diamino-N-benzylpyrrolidine, 1R,2R-trans-diaminocycloheptane, 5R,6R-trans-5,6-diaminoindan, 1 S-phenyl-1,2-ethanediamine, and the mirror image counterpart of any of the above.
- 12. The composition of claim 1, wherein said ligand L1 is selected from ligands represented herein as I through XV and the mirror image counterpart of any of the above.
- 13. The composition of claim 1, wherein said metal atom is molybdenum.
- 14. A catalytic organometallic composition, effective to catalyze the enantioselective alkylation of an allyl group bearing a leaving group at an allylic position, wherein the composition is the product of a process which comprises:
contacting with a chiral ligand L1, in a suitable solvent, a soluble complex of a metal selected from tungsten (0), chromium (0), and molybdenum(0), having ligands which form a stable complex with the metal and are displaceable by ligand L1 under the conditions of said contacting, wherein said ligand L1 comprises:
a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group —NH—(C═O)'B, wherein said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; each group B is selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp2 hybridized ring nitrogen atom effective to coordinate to said metal atom; and at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring; whereby said complex undergoes a ligand exchange reaction, such that chiral ligand L1 becomes coordinated to said metal atom.
- 15. The composition of claim 14, wherein in said process said metal is molybdenum (0).
- 16. The composition of claim 14, wherein in said process said soluble complex comprises ligands selected from the group consisting of CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile.
- 17. The composition of claim 14, wherein
(i) each said group B is a group CyN as defined in claim 14, or (ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim 14; or (iii) both (i) and (ii) are present.
- 18. The composition of claim 14, wherein at least one group B is a group CyN having an sp2 hybridized ring nitrogen which is a to a ring carbon atom which is linked to the carbonyl (C═O) carbon of said binding group.
- 19. The composition of claim 14, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring.
- 20. The composition of claim 19, wherein said ring is a 5- to 7- membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon, and may be fused to an additional ring.
- 21. The composition of claim 20, wherein said heterocyclic ring has 1 to 2 ring atoms selected from oxygen and nitrogen.
- 22. The composition of claim 14, wherein said group or groups CyN are independently selected from pyridyl, quinolinyl, isoquinolyl, pyrimidyl, triazinyl, tetrazinyl, pyrazinyl, pyrazolyl, triazolyl, tetrazolyl, oxazinyl, oxazolyl, thiazolyl, imidazolyl, benzoxazole, benzimidazole, and dihydro derivatives of the above.
- 23. The composition of claim 18, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, 2-benzoxazole, 2-benzimidazole, and dihydro derivatives of the above.
- 24. The composition of claim 14, wherein said carbon atoms are connected by a direct bond.
- 25. The composition of claim 24, wherein said chiral component is selected from 1R,2R-trans-diaminocyclohexane, 1R,2R-trans-diphenyl-1,2-ethanediamine, 3R,4R-trans-3,4-diamino-N-benzylpyrrolidine, 1R,2R-trans-diaminocycloheptane, 5R,6R-trans-5,6-diaminoindan, 1 S-phenyl-1,2-ethanediamine, and the mirror image counterpart of any of the above.
- 26. The composition of claim 14, wherein said ligand L1 is selected from ligands represented herein as I through XV and the mirror image counterpart of any of the above.
- 27. A method of selective alkylation of an allyl group bearing a leaving group at an allylic position, said method comprising
reacting a substrate containing said allyl group with an alkylating agent in the presence of a catalytic composition formed by contacting, in a suitable solvent, catalytic amounts of: (i) a chiral ligand L1, and (ii) a soluble complex of a metal selected from the group consisting of molybdenum (0), tungsten (0), and chromium (0), having ligands which form a stable complex with the metal and are displaceable by ligand L1 under the conditions of said contacting, under conditions effective to produce an alkylated substrate which is enriched in one of the possible isomeric products of such alkylation, wherein said chiral ligand L1 comprises:
a chiral component derived from a chiral diamine, said component comprising first and second carbon atoms, each bearing a binding group —NH—(C═O)—B, wherein said carbon atoms are connected by a direct bond or by a chain of one to three atoms comprising linkages selected from alkyl, alkyl ether, alkyl amino, and combinations thereof; each group B is selected from alkyl, cycloalkyl, heterocycle, aryl, and aralkyl; at least one group B is a N-heterocyclic or N-heteroaryl group CyN having an sp2 hybridized ring nitrogen atom effective to coordinate to said metal atom; and at least one of said carbon atoms is a chiral carbon atom bearing a further substituent, wherein said substituent or substituents are independently selected from aryl, aralkyl, carbocycle, heterocycle, and secondary or tertiary alkyl having 3 or more carbons, and where substituents on adjacent chiral carbon atoms may together form a ring.
- 28. The method of claim 27, wherein said alkylation is enantioselective, and produces an alkylated substrate having an enantiomeric excess greater than 75%.
- 29. The method of claim 27, wherein said allyl group is nonsymmetrically substituted at its termini, and said alkylating is regioselective, such that said allyl group is alkylated predominantly at its more sterically hindered terminus.
- 30. The method of claim 27, wherein, in said ligand L1,
(i) each said group B is a group CyN as defined in claim 27, or (ii) each said carbon atom is a chiral carbon atom bearing a substituent as defined in claim 27; or (iii) both (i) and (ii) are present.
- 31. The method of claim 27, wherein at least one group B is a group CyN having an sp2 hybridized ring nitrogen which is α to a ring carbon atom which is linked to the carbonyl (C═O) carbon of said binding group.
- 32. The method of claim 27, wherein said carbon atoms are connected by a direct bond.
- 33. The method of claim 32, wherein each said carbon atom is a chiral carbon atom bearing a substituent, and said substituents are independently aryl or together form a ring.
- 34. The method of claim 33, wherein said ring is a 5- to 7-membered carbocyclic ring, or a 5- to 7-membered heterocyclic ring having 1 to 3 ring atoms selected from oxygen, nitrogen and sulfur and the remaining ring atoms carbon.
- 35. The method of claim 31, wherein said group or groups CyN are independently selected from 2-pyridyl, 2-quinolinyl, 1- or 3-isoquinolyl, 2- or 4-pyrimidyl, 2-triazinyl, 4-tetrazinyl, 2-pyrazinyl, 3- or 5-pyrazolyl, 3- or 5-triazolyl, 2-tetrazolyl, 2-oxazinyl, 2- or 5-oxazolyl, 2- or 5-thiazolyl, 2- or 4-imidazolyl, and dihydro derivatives of the above.
- 36. The method of claim 27, wherein neither terminus of said allyl group is aryl substituted.
- 37. The method of claim 27, wherein the alkylating agent is a stabilized carbanion of the form EE′RC− M+, where M+ is a positively charged counterion, and each of E and E' is an electron-withdrawing substituent selected from keto, carboxylic ester, cyano, and sulfonyl, or an aromatic or heteroaromatic group capable of stabilizing an α-carbanion.
- 38. The method of claim 37, wherein at least one of E and E′ is a carboxylic ester.
- 39. The method of claim 27, wherein said metal atom is molybdenum.
- 40. The method of claim 39, wherein said soluble molybdenum(0) complex bears ligands selected from the group consisting of CO, cycloheptatriene, lower alkyl nitrile, and lower alkyl isonitrile.
- 41. The method of claim 27, wherein the mole percent of said catalytic composition with respect to said substrate is from about 0.5% to about 15%.
Parent Case Info
[0001] This application is a continuation-in-part of U.S. Ser. No. 09/498,701, filed Feb. 7, 2000, which is divisional of U.S. Ser. No. 09/213,395, filed Dec. 15, 1998, now U.S. Pat. No. 6,130,349, which claims the priority of U.S. Provisional Serial No. 60/068,128, filed Dec. 19, 1997, all of which are incorporated herein by reference in their entirety.
Government Interests
[0002] This invention was made with government support under National Institutes of Health Grant No. 5R37 GM13598-30 and National Science Foundation Grant No. CHE-9501472. Accordingly, the United States Government has certain rights in this invention.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60068128 |
Dec 1997 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09213395 |
Dec 1998 |
US |
Child |
09498701 |
Feb 2000 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09498701 |
Feb 2000 |
US |
Child |
09949467 |
Sep 2001 |
US |